Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-619-7 | CAS number: 3558-60-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from experimental study report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Principles of method if other than guideline:
- The objective of this acute oral toxicity study was to assess the toxicological profile of the test item when administered to rats by a single oral gavage.
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- no
Test material
- Reference substance name:
- (2-methoxyethyl)benzene
- EC Number:
- 222-619-7
- EC Name:
- (2-methoxyethyl)benzene
- Cas Number:
- 3558-60-9
- Molecular formula:
- C9-H12-O
- IUPAC Name:
- (2-methoxyethyl)benzene
- Test material form:
- liquid
- Details on test material:
- - Name of test material: Benzene(-2-methoxyethyl)
- Molecular formula: C9H12O
- Molecular weight: 136.193 g/mole
- Smiles : COCCc1ccccc1
- Inchl: InChI=1/C9H12O/c1-10-8-7-9-5-3-2-4-6-9/h2-6H,7-8H2,1H3
- Substance type: Organic
- Physical state: Liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material: (2-methoxy ethyl) benzene
- Molecular formula: C9H12O
- Molecular weight: 136.193 g/mole
- Smiles : COCCc1ccccc1
- Inchl: InChI=1/C9H12O/c1-10-8-7-9-5-3-2-4-6-9/h2-6H,7-8H2,1H3
- Substance type: Organic
- Physical state: Clear colourless, mobile liquid, almost insoluble in water
- Purity as per Certificate of Analysis : 99.7302%
- Lot No. : PE0201/18
- Manufactured date : Jan 2018
- Expiry Date : Dec 2022
- pH : 3.98 at 26.8°C
- Density : 0.952g/cm3
- Storage conditions : Ambient (+18 to +36ºC)
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: In-vivo Biosciences,Karnataka,India
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 10 to 12 weeks
- Weight at study initiation: 207.5 to 226.5 g
- Identification:By rat accession number, cage card and turmeric colour body marking. The rat accession numbers were allotted during the course of the study. The temporary body marking during acclimatization period was done with crystal violet.
- Fasting period before study: rats were fasted for approximately 16 to 18 hours
- Housing:Rats were housed individually in standard polysulfone cages (Size: L 425 x B 266 x H 185 mm), with stainless steel top grill
- Diet (e.g. ad libitum): Hypro Rat & Mice pellet feed, ad libitum
- Water (e.g. ad libitum): Deep bore-well water passed through activated charcoal filter and exposed to UV rays in Aquaguard on-line water filter-cum-purifier, Mumbai, ad libitum
- Acclimation period: the animals were acclimatized for six to twenty two days (Steps 1 to 7) under laboratory conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 25°C
- Humidity (%):64 to 68%
- Air changes (per hr): air conditioned with adequate fresh air supply (between 13.13 and 14.1 air changes/hour).
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours dark cycle.
IN-LIFE DATES: From: 05 December 2018 To: 05 January 2019
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 2000 and 550 mg/kg bw.
- Amount of vehicle (if gavage):2.1 mL/kg body weight to attain the dose of 2000 mg/kg body weight (Step 1, 3, 5 and 7) and 0.58 mL/kg body weight to attain the dose of 550 mg/kg body weight (Step 2, 4, 6) respectively.
MAXIMUM DOSE VOLUME APPLIED: 2.1 mL/kg body weight
- Doses:
- Step 1 :2000 mg/kg body weight
Step 2 :550 mg/kg body weight
Step 3 :2000 mg/kg body weight
Step 4 :550 mg/kg body weight
Step 5: 2000 mg/kg body weight
Step 6 :550 mg/kg body weight
Step 7 :2000 mg/kg body weight - No. of animals per sex per dose:
- TOTAL: 7 animals
Step 1 :2000 mg/kg body weight :1
Step 2 :550 mg/kg body weight:1
Step 3 :2000 mg/kg body weight:1
Step 4 :550 mg/kg body weight:1
Step 5: 2000 mg/kg body weight:1
Step 6 :550 mg/kg body weight:1
Step 7 :2000 mg/kg body weight:1 - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
- Clinical signs and pre-terminal deaths:The animals were observed five times on test day 1 (day of administration) i.e., at 30 minutes and 1, 2, 3 and 4 hours after dose administration and once daily during days 2 to 15. Additional observation was done for Rw2351, Rw2353 and Rw2357.Observation was included changes in skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behaviour pattern. All observed clinical signs were recorded.
- Body weights:Individual body weights of animals were recorded on test day 1 (Pre-administration), day 8 (7 days post administration) and day 15 (14 days post administration) and at death.
- Necropsy of survivors performed: yes, At the end of the observation period all the surviving rats were euthanized by using deep isoflurane anaesthesia and the pre-terminally dead animals were also subjected to detailed necropsy by an experienced prosector. Microscopic examination was not carried out as no gross pathological changes were observed. - Statistics:
- not specified
Results and discussion
- Preliminary study:
- As per the Material Safety Data Sheet provided by the Sponsor, the acute oral LD50 of test chemical in rats is 2292.314 mg/kg body weight. Hence the study was initiated with the starting dose of 2000 mg/kg body weight (Step 1). The rat died and as per the AOT425 Statistical program, the six rats (Step 2 to Step 7) were administered with dose of 550, 2000, 550, 2000, 550 and 2000 mg/kg sequentially. The stopping criteria was met with 5 reversals occurred in 6 consecutive animals tested (as per AOT statistical program).Dose progression and stopping criteria was calculated using a dedicated software program (Acute Oral Toxicity (Guideline 425) Statistical Program) provided by the EPA.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 049 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 550 - <= 2 000
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- 2000 mg/kg body weight – Step 1: animal found dead on during day 3 observation.
2000 mg/kg body weight – Step 3: animal found dead on during end of treatment day 1 observation.
2000 mg/kg body weight – Step 5: animal found dead on 4th hour post dose observation.
2000 mg/kg body weight – Step 7: animal found dead on day 2.
550 mg/kg body weight – Step 2, 4 and 6: no pre-terminal deaths were observed. - Clinical signs:
- other: 2000 mg/kg body weight – Step 1: Slight ataxia was observed during 4th hour post dose to end of the treatment day1 and recumbent, slight lacrimation, dyspnoea on day 2 observation. 2000 mg/kg body weight – Step 3: Slight ataxia was observed 3rd hour post
- Gross pathology:
- There were no abnormalities detected at necropsy.
- Other findings:
- not specified
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Based on the results, the acute oral LD50 value for the given test chemical is considered to be 1049 mg/kg body weight (approximate 95% confidence interval is 550 to 2000) in female wistar rats.The test item is classified as “Category 4 (300-2000 mg/kg bw)” as per the criteria of CLP.
- Executive summary:
The acute oral toxicity study was conducted to assess the toxicological profile of the given test item (2-methoxy ethyl) benzene (CAS no.: 3558 -60 -9, E.C. no.: 222 -619 -7) as per OECD Guideline 425 ( Acute Oral Toxicity -Up-and-Down Procedure, adopted- 3rd october 2008), in Wistar rats to produce toxicity when a single dose was administered via the oral route.The undiluted test item was administered as a single oral gavage to rats fasted for 16 to 18 hours.In Preliminary test,the acute oral LD50 of test chemical in rats was considered to be 2292.314 mg/kg body weight. Hence the study was initiated with the starting dose of 2000 mg/kg body weight (Step 1). The rat died and as per the AOT425 Statistical program, the six rats (Step 2 to Step 7) were administered with dose of 550, 2000, 550, 2000, 550 and 2000 mg/kg sequentially. The stopping criteria was met with 5 reversals occurred in 6 consecutive animals tested.Dose progression and stopping criteria was calculated using a dedicated software program (Acute Oral Toxicity (Guideline 425) Statistical Program) provided by the EPA.Clinical signs and pre-terminal deaths, Body weights and Necropsy were observed in treated animals.At dose 2000 mg/kg body weight (Step 1) Slight ataxia was observed during 4th hour post dose to end of the treatment day1 and recumbent, slight lacrimation, dyspnoea on day 2 were observed and found dead on during day 3 observation.At dose 2000 mg/kg body weight (Step 3) Slight ataxia was observed 3rd hour post dose with recumbent and dyspnoea 4th hour post dose and found dead on during end of treatment day 1 observation.At dose 2000 mg/kg body weight (Step 5) moderate tremors and gasping were observed during 3rd hour post dose.At dose 2000 mg/kg body weight (Step 7) hypoactivity observed 3rd hour to 4th hour post dose with respect to recumbent which was observed on end of the treatment day 1 and found dead on day 2.At dose 550 mg/kg body weight (Step 2, 4 and 6) there were no clinical signs of toxicity and no pre-terminal deaths were observed.Changes in body weight were seen at dose 2000 mg/kg body weight (Step 1, 3, 5 and 7) and 550 mg/kg body weight (Step 2, 4 and 6). There were no abnormalities detected at necropsy.Based on the results of the present study, the LD50 value for the given test chemical is considered to be 1049 mg/kg (approximate 95% confidence interval is 550 to 2000).Therefore, The test item is classified as “Category 4 (300-2000 mg/kg bw)” as per the criteria of CLP. This test was performed according to GLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.